These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8395599)

  • 1. Tannins as potent inhibitors of DNA topoisomerase II in vitro.
    Kashiwada Y; Nonaka G; Nishioka I; Lee KJ; Bori I; Fukushima Y; Bastow KF; Lee KH
    J Pharm Sci; 1993 May; 82(5):487-92. PubMed ID: 8395599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA topoisomerases by sanguiin H-6, a cytotoxic dimeric ellagitannin from Sanguisorba officinalis.
    Bastow KF; Bori ID; Fukushima Y; Kashiwada Y; Tanaka T; Nonaka G; Nishioka I; Lee KH
    Planta Med; 1993 Jun; 59(3):240-5. PubMed ID: 8391144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.
    Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK
    Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor agents. 124. New 4 beta-substituted aniline derivatives of 6,7-O,O-demethylene-4'-O-demethylpodophyllotoxin and related compounds as potent inhibitors of human DNA topoisomerase II.
    Wang ZQ; Hu H; Chen HX; Cheng YC; Lee KH
    J Med Chem; 1992 Mar; 35(5):871-7. PubMed ID: 1312601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition.
    Jensen LH; Renodon-Corniere A; Wessel I; Langer SW; Søkilde B; Carstensen EV; Sehested M; Jensen PB
    Mol Pharmacol; 2002 May; 61(5):1235-43. PubMed ID: 11961142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Woodfruticosin (woodfordin C), a new inhibitor of DNA topoisomerase II. Experimental antitumor activity.
    Kuramochi-Motegi A; Kuramochi H; Kobayashi F; Ekimoto H; Takahashi K; Kadota S; Takamori Y; Kikuchi T
    Biochem Pharmacol; 1992 Nov; 44(10):1961-5. PubMed ID: 1333201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ortho-quinone metabolite of the anticancer drug etoposide (VP-16) is a potent inhibitor of the topoisomerase II/DNA cleavable complex.
    Gantchev TG; Hunting DJ
    Mol Pharmacol; 1998 Mar; 53(3):422-8. PubMed ID: 9495807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase II cleavage of telomeres in vitro and in vivo.
    Yoon HJ; Choi IY; Kang MR; Kim SS; Muller MT; Spitzner JR; Chung IK
    Biochim Biophys Acta; 1998 Jan; 1395(1):110-20. PubMed ID: 9434158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased phosphorylation of DNA topoisomerase II in etoposide-resistant mutants of human cancer KB cells.
    Takano H; Kohno K; Ono M; Uchida Y; Kuwano M
    Cancer Res; 1991 Aug; 51(15):3951-7. PubMed ID: 1649696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postincubation with aclarubicin reverses topoisomerase II mediated DNA cleavage, strand breaks, and cytotoxicity induced by VP-16.
    Petersen LN; Jensen PB; Sørensen BS; Engelholm SA; Spang-Thomsen M
    Invest New Drugs; 1994; 12(4):289-97. PubMed ID: 7775129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 4 beta-arylamino derivatives of 4'-O-demethylepipodophyllotoxin on human DNA topoisomerase II, tubulin polymerization, KB cells, and their resistant variants.
    Chang JY; Han FS; Liu SY; Wang ZQ; Lee KH; Cheng YC
    Cancer Res; 1991 Apr; 51(7):1755-9. PubMed ID: 1848478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of unstimulated human lymphocytes and DNA strand breaks induced by the topoisomerase II inhibitor etoposide (VP-16).
    Tronov VA; Konoplyannikov MA; Nikolskaya TA; Konstantinov EM
    Biochemistry (Mosc); 1999 Mar; 64(3):345-52. PubMed ID: 10205305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of DNA cleavage induced by etoposide and doxorubicin in two human small-cell lung cancer lines with different sensitivities to topoisomerase II inhibitors.
    Binaschi M; Capranico G; De Isabella P; Mariani M; Supino R; Tinelli S; Zunino F
    Int J Cancer; 1990 Feb; 45(2):347-52. PubMed ID: 2154411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic and DNA-damaging properties of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA) and its analogues.
    Pastwa E; Ciesielska E; Piestrzeniewicz MK; Denny WA; Gniazdowski M; Szmigiero L
    Biochem Pharmacol; 1998 Aug; 56(3):351-9. PubMed ID: 9744573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.
    Chen GL; Yang L; Rowe TC; Halligan BD; Tewey KM; Liu LF
    J Biol Chem; 1984 Nov; 259(21):13560-6. PubMed ID: 6092381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells.
    Fattman CL; Allan WP; Hasinoff BB; Yalowich JC
    Biochem Pharmacol; 1996 Aug; 52(4):635-42. PubMed ID: 8759037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives alpha-lapachone and beta-lapachone.
    Krishnan P; Bastow KF
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):187-98. PubMed ID: 11320661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
    Benchokroun Y; Couprie J; Larsen AK
    Biochem Pharmacol; 1995 Jan; 49(3):305-13. PubMed ID: 7857317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.